Bcl-2 expression in carcinoma of the uterine cervix and its relationship with prognostic variables

Kaynakça (16)

1. Blaustein A. Blaustein pathology of the female genital tract. Fourth edition Springer Verlag. New York 439-486, 1999
2. Comoel et al. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 144(6): 1195-1202, 1994
3. Hockenbery DM, Nunez G, Milliman C et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature; 348: 334-346, 1990
4. Hockenbery DM, Zutter M, Hickey W et al. Bcl-2 protein is topograpically restricted in tissues characterized by apoptotic cell death. Proc. Nat Acad. Sci. USA; 88: 6961-6965, 1991
5. Pezzela F, Tse AGD, Cordell JL et al. Expression of Bcl-2 oncogene protein is not specific for the 14,18 choromosomal translocation Am J Pathol; 137(2): 225-232, 1990
6. Monaghan et al. Ultrastructural localization of Bcl-2 protein J Histochem: Cytochem. 10(12): 1819- 1825, 1992
7. Le Brun DP, Warnke RA, Clearly ML. Expression of Bcl-2 in fetal tissues suggests a role in morphogenesis Am. J. Pathol; 169: 431-437, 1993
8. Lu Long Ql, Poulsorn R, Wang L, Hanby AM. Bcl-Expression in adult and embryonic non haemotopoietic tissues J Pathol; 169: 431-437, 1993
9. Zeng W, Cao P, Zheng M et al. P53 over-expression and Bcl-2 persistence in endometrial carcinoma: Comparison of papillary, serous and endometrioid subtypes. Gynecol Oncol; 61: 167-174, 1996
10. Rajkumar T, Rajan S, Baruch RK et al. Prognostic significance of Bcl-2 and P53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix Eur J Gynaecol Oncol. 19(6): 556-60, 1998
11. Tjalma W, De Cuyper E, Weyler J et al. Expression of Bcl-2 in invasive and in situ carcinoma of the uterine cervix; Am J Obstet Gynecol; 178 (1 pt 1): 133-7, 1998
12. Tjalma W, Van Marck E, De Rooter C et al. Prognostic value of Bcl-2 expression in patients with operable carcinoma of the uterine cervix J Clin Pathol; 50(1): 33-6, 1997
13. Kokawa S, Shikone T, Otani T, Naknof. Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Cancer, 85(8): 1799-809, 1999
14. Harima Y, Nagata K, Harima K et al. Bax and bcl-expressions predict response to radiotherapy in human cervical cancer. J Cancer Res Clin Oncol. 124 (9): 503- 510, 1998
15. Pillai MR, Jayaprakash PG, Nair MK. Bcl-2 immuno reactivity but not p53 accumulation associated with tumor response to radiotherapy in cervical carcinoma J Cancer Res Clin Oncol; 125(1): 55-60, 1999
16. Crawford RA et al. Prognostic signific